Clinical and experimental advances in treatment of visceral leishmaniasis

Antimicrob Agents Chemother. 2001 Aug;45(8):2185-97. doi: 10.1128/AAC.45.8.2185-2197.2001.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antiprotozoal Agents / therapeutic use*
  • Humans
  • Immunotherapy
  • Leishmaniasis, Visceral / drug therapy*

Substances

  • Antiprotozoal Agents